To donate by check, phone, or other method, see our More Ways to Give page.
A patient is treated for the flu in Louisiana. Healthcare costs in the U.S. were found to be twice as high as those in ten other developed countries because of high prices across the healthcare industry--from doctor's salaries to prescription drugs. (Photo: Mario Villafuerte/Getty Images)
Yet another report shows how relying on a for-profit, private-insurance based healthcare model is driving up costs for people living in the U.S. while delivering poor outcomes.
New research shows that high healthcare spending in the U.S. stems not just from elevated prescription drug costs or its fee-for-service model--but from high costs across the American healthcare industry.
Researchers from Harvard University's T.H. Chan School of Public Health compared healthcare costs and outcomes in the U.S. to those in ten other developed countries, including the U.K, Canada, Japan, and France.
The U.S. spends two times as much as the other high-income nations included in the study, paying its doctors far more and allowing its drug prices to skyrocket well beyond those of its counterparts.
Doctors in the U.S. are paid an average of about $218,000, compared with physicians in other countries who earn between $86,000 and $154,000 per year. Per capita spending for prescription drugs is also about $500 to $900 higher in the U.S. than it is in the 10 other countries studied.
Several of the countries the U.S. was compared to have government-run universal healthcare systems, while some including Switzerland and the Netherlands subsidize healthcare costs for many citizens.
"Only the United States has a voluntary, private employer-based, and individual-based system," noted the study. "The majority of the countries do not have private insurance as the primary form of insurance."
"Most countries get to lower prices one of two ways: they either have a very strong price setter, usually a government agency, or more efficient markets," Dr. Ashish Jha, co-author of the study, which was published in the Journal of the American Medical Association, told the Guardian. "The U.S. has figured out how to do the worst of both."
While the U.S. spends far more on its doctors, medications, and administrative healthcare costs, it has much worse outcomes than countries that ensure every citizen has free or affordable healthcare.
Life expectancy in the U.S. was the lowest of the 11 countries surveyed, and its rates of maternal and infant mortality were the highest.
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. The final deadline for our crucial Summer Campaign fundraising drive is just hours away, and we’re falling short of our must-hit goal. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Yet another report shows how relying on a for-profit, private-insurance based healthcare model is driving up costs for people living in the U.S. while delivering poor outcomes.
New research shows that high healthcare spending in the U.S. stems not just from elevated prescription drug costs or its fee-for-service model--but from high costs across the American healthcare industry.
Researchers from Harvard University's T.H. Chan School of Public Health compared healthcare costs and outcomes in the U.S. to those in ten other developed countries, including the U.K, Canada, Japan, and France.
The U.S. spends two times as much as the other high-income nations included in the study, paying its doctors far more and allowing its drug prices to skyrocket well beyond those of its counterparts.
Doctors in the U.S. are paid an average of about $218,000, compared with physicians in other countries who earn between $86,000 and $154,000 per year. Per capita spending for prescription drugs is also about $500 to $900 higher in the U.S. than it is in the 10 other countries studied.
Several of the countries the U.S. was compared to have government-run universal healthcare systems, while some including Switzerland and the Netherlands subsidize healthcare costs for many citizens.
"Only the United States has a voluntary, private employer-based, and individual-based system," noted the study. "The majority of the countries do not have private insurance as the primary form of insurance."
"Most countries get to lower prices one of two ways: they either have a very strong price setter, usually a government agency, or more efficient markets," Dr. Ashish Jha, co-author of the study, which was published in the Journal of the American Medical Association, told the Guardian. "The U.S. has figured out how to do the worst of both."
While the U.S. spends far more on its doctors, medications, and administrative healthcare costs, it has much worse outcomes than countries that ensure every citizen has free or affordable healthcare.
Life expectancy in the U.S. was the lowest of the 11 countries surveyed, and its rates of maternal and infant mortality were the highest.
Yet another report shows how relying on a for-profit, private-insurance based healthcare model is driving up costs for people living in the U.S. while delivering poor outcomes.
New research shows that high healthcare spending in the U.S. stems not just from elevated prescription drug costs or its fee-for-service model--but from high costs across the American healthcare industry.
Researchers from Harvard University's T.H. Chan School of Public Health compared healthcare costs and outcomes in the U.S. to those in ten other developed countries, including the U.K, Canada, Japan, and France.
The U.S. spends two times as much as the other high-income nations included in the study, paying its doctors far more and allowing its drug prices to skyrocket well beyond those of its counterparts.
Doctors in the U.S. are paid an average of about $218,000, compared with physicians in other countries who earn between $86,000 and $154,000 per year. Per capita spending for prescription drugs is also about $500 to $900 higher in the U.S. than it is in the 10 other countries studied.
Several of the countries the U.S. was compared to have government-run universal healthcare systems, while some including Switzerland and the Netherlands subsidize healthcare costs for many citizens.
"Only the United States has a voluntary, private employer-based, and individual-based system," noted the study. "The majority of the countries do not have private insurance as the primary form of insurance."
"Most countries get to lower prices one of two ways: they either have a very strong price setter, usually a government agency, or more efficient markets," Dr. Ashish Jha, co-author of the study, which was published in the Journal of the American Medical Association, told the Guardian. "The U.S. has figured out how to do the worst of both."
While the U.S. spends far more on its doctors, medications, and administrative healthcare costs, it has much worse outcomes than countries that ensure every citizen has free or affordable healthcare.
Life expectancy in the U.S. was the lowest of the 11 countries surveyed, and its rates of maternal and infant mortality were the highest.